Yayın: Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents
| dc.contributor.author | Zahra, Maryam | |
| dc.contributor.author | ULVİYE, ACAR | |
| dc.contributor.author | Emine Terzi | |
| dc.contributor.author | Tuba Özdemir-Sancı | |
| dc.contributor.author | Maryam Zahra | |
| dc.contributor.author | Ulviye Acar Çevik | |
| dc.contributor.orcid | 0000-0002-8490-6293 | |
| dc.contributor.orcid | 0000-0002-0596-834X | |
| dc.contributor.orcid | 0000-0001-9106-3848 | |
| dc.contributor.orcid | 0000-0002-9468-4719 | |
| dc.contributor.orcid | 0000-0003-4233-727X | |
| dc.contributor.orcid | 0000-0003-1879-1034 | |
| dc.date.accessioned | 2025-11-13T12:09:22Z | |
| dc.date.issued | 2024-12-01 | |
| dc.identifier.doi | https://doi.org/10.1111/cbdd.70033 | |
| dc.identifier.endpage | e70033 | |
| dc.identifier.issn | 1747-0277 | |
| dc.identifier.issue | 6 | |
| dc.identifier.openalex | W4405383595 | |
| dc.identifier.startpage | e70033 | |
| dc.identifier.uri | https://hdl.handle.net/11421/9136 | |
| dc.identifier.uri | https://doi.org/10.1111/cbdd.70033 | |
| dc.identifier.volume | 104 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Chemical Biology & Drug Design | |
| dc.rights | restrictedAccess | |
| dc.subject | Benzimidazole | |
| dc.subject | Apoptosis | |
| dc.subject | Chemistry | |
| dc.subject | Cisplatin | |
| dc.subject | Cell cycle checkpoint | |
| dc.subject | Cell culture | |
| dc.subject | Cell cycle | |
| dc.subject | Cell growth | |
| dc.subject | Stereochemistry | |
| dc.subject | Biochemistry | |
| dc.subject | Biology | |
| dc.subject | Organic chemistry | |
| dc.subject.sdg | 3 | |
| dc.title | Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5101488032 | |
| local.authorid.openalex | A5047270177 |
